Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-01-04 @ 11:59 PM
Study NCT ID:
NCT04246866
Status:
COMPLETED
Last Update Posted:
2021-02-11
First Post:
2020-01-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration
Sponsor:
Gemini Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-06
First Submit QC Date:
None
Study First Post Date:
2020-01-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-09
Last Update Post Date:
2021-02-11
Last Update Post Date Type:
ACTUAL